47 results
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
19 Mar 24
Cytek® Biosciences Names William McCombe Chief Financial Officer
5:00pm
Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
1 Mar 24
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
6:06am
contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
9 Jan 24
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
6:05am
.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
28 Nov 23
Regulation FD Disclosure
7:00am
This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among
8-K
EX-99.1
4hx66ncwkn lknihspf
7 Nov 23
Cytek Biosciences Reports Third Quarter 2023 Financial Results
4:45pm
8-K
EX-99.1
71evm6529b 5128y
8 Aug 23
Cytek Biosciences Reports Second Quarter 2023 Financial Results
4:17pm
8-K
EX-99.1
0vfhfw4 ka
9 May 23
Cytek Biosciences Reports First Quarter 2023 Financial Results
4:24pm
8-K
EX-99.1
xzygoxdlyeh6lgcjdbi
9 Nov 22
Cytek Biosciences Reports Third Quarter 2022 Financial Results
4:24pm
8-K
EX-99.1
9hhq1p6
1 Nov 22
Cytek® Biosciences Names Chris Williams Chief Operating Officer
5:16pm
S-3ASR
EX-4.4
c6vgn wx96hmhx1
26 Aug 22
Automatic shelf registration
5:07pm
S-3ASR
EX-1.2
hvis0hn f4tc
26 Aug 22
Automatic shelf registration
5:07pm
S-3ASR
sxz86mj8
26 Aug 22
Automatic shelf registration
5:07pm
8-K
EX-99.1
viomb7lstxowfbdpz6s
10 Aug 22
Cytek Biosciences Reports Second Quarter 2022 Financial Results
4:17pm